Biostage, Inc. (BSTG): Thomas Mcnaughton , CFO of Biostage, Inc. purchased 5,000 shares on May 20, 2016. The Insider buying transaction was reported by the company on May 23, 2016 to the Securities and Exchange Commission. The shares were purchased at $1.55 per share for a total value of $7,775.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 23, 2016, James Joseph Mcgorry (CEO) purchased 10,000 shares at $1.56 per share price.
Company has been under the radar of several Street Analysts.Biostage, Inc. is Resumed by Maxim Group to Buy and the brokerage firm has set the Price Target at $8. The Rating was issued on Apr 7, 2016.